As novel gene therapies emerge, there is a complex interplay among their potential benefits, the burdens they may impose and ...

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Kenan R. Omurtag, M.D., discusses how less invasive fertility treatments like lifestyle modifications, ovulation induction ...

The panelist discusses how intracytoplasmic sperm injection can be used in conjunction with in vitro fertilization (IVF) to ...

Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...